Ysios Capital

Ysios Capital is a leading European venture capital firm focused on life sciences. They invest globally in biotech ventures developing novel therapeutic drugs, supporting companies through preclinical and clinical development. Their investment thesis prioritizes strong scientific foundations, exceptional teams, and indications with high unmet medical needs.

Founded 2008 · Venture Capital

San Sebastian (Spain), Barcelona (Spain)

Investment Stages

Series A

Series B

Series C

Markets

Biotechnology

Pharmaceuticals

Medical Technology

Therapeutics

Portfolio Companies

Acendo, AELIX Therapeutics, AM Pharma, Anaconda Biomed, Aura Biosciences, Babyscripts, BioVex, CorWave, CVRx, Cytoki Pharma, EndoSense, Engrail Therapeutics, Fusion Pharmaceuticals, Galecto Biotech, Inbiomotion, KALA BIO, Kynexis, LAVA Therapeutics, MedLumics, Memo Therapeutics, Mineralys Therapeutics, Minoryx Therapeutics, Neurona Therapeutics, Northsea Therapeutics, Ona Therapeutics, OxThera, Prexton Therapeutics, Sanifit, SparingVision, SpliceBio, STAT Dx, Synendos, Tagworks Pharmaceuticals, TiGenix, VarmX, Vivet Therapeutics, Xeltis

Links

Website Team Page Portfolio LinkedIn X Crunchbase PitchBook

Related VC firms in Spain

COLUMBUS VENTURE PARTNERS

Biotechnology, Medical Technology, Pharmaceuticals, Healthcare

Adara Ventures

Cybersecurity, Energy Transition, Data & AI, Digital Health, Components, Digital Infrastructure

Asabys Partners

Healthcare, Life-sciences

Share this page

Want more backlinks, traffic, and startup visibility?

Get your startup listed in 100+ directories automatically. Perfect for SaaS, AI, and tech startups.

Submit Your Startup